154 related articles for article (PubMed ID: 3291447)
21. Construction of synthetic immunogen: use of new T-helper epitope on malaria circumsporozoite protein.
Good MF; Maloy WL; Lunde MN; Margalit H; Cornette JL; Smith GL; Moss B; Miller LH; Berzofsky JA
Science; 1987 Feb; 235(4792):1059-62. PubMed ID: 2434994
[TBL] [Abstract][Full Text] [Related]
22. Cell-mediated immune responses to vaccine peptides derived from the circumsporozoite protein of Plasmodium falciparum.
Russo DM; Sundy JS; Young JF; Maguire HC; Weidanz WP
J Immunol; 1989 Jul; 143(2):655-9. PubMed ID: 2472448
[TBL] [Abstract][Full Text] [Related]
23. T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites.
Nardin E; Munesinghe YD; Moreno A; Clavijo P; Calle MC; Edelman R; Davis J; Herrington D; Nussenzweig RS
Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():223-7. PubMed ID: 1364202
[TBL] [Abstract][Full Text] [Related]
24. Human lymphocyte proliferative response to a sporozoite T cell epitope correlates with resistance to falciparum malaria.
Hoffman SL; Oster CN; Mason C; Beier JC; Sherwood JA; Ballou WR; Mugambi M; Chulay JD
J Immunol; 1989 Feb; 142(4):1299-303. PubMed ID: 2464643
[TBL] [Abstract][Full Text] [Related]
25. [Recent findings on the molecular biology of Plasmodium antigens].
Jaureguiberry G; Mercereau-Puijalon O
Bull Soc Pathol Exot Filiales; 1985; 78(2):179-90. PubMed ID: 2411439
[TBL] [Abstract][Full Text] [Related]
26. Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum.
Lupski JR
N Engl J Med; 1987 Feb; 316(7):415. PubMed ID: 3100954
[No Abstract] [Full Text] [Related]
27. Small variant surface antigens and Plasmodium evasion of immunity.
Jemmely NY; Niang M; Preiser PR
Future Microbiol; 2010 Apr; 5(4):663-82. PubMed ID: 20353305
[TBL] [Abstract][Full Text] [Related]
28. The real difficulties for malaria sporozoite vaccine development: nonresponsiveness and antigenic variation.
Good MF; Kumar S; Miller LH
Immunol Today; 1988 Nov; 9(11):351-5. PubMed ID: 3076406
[No Abstract] [Full Text] [Related]
29. Development of asexual erythrocytic malaria vaccines.
Chulay JD
Prog Clin Biol Res; 1989; 313():13-21. PubMed ID: 2675112
[No Abstract] [Full Text] [Related]
30. Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum.
Ballou WR; Rothbard J; Wirtz RA; Gordon DM; Williams JS; Gore RW; Schneider I; Hollingdale MR; Beaudoin RL; Maloy WL
Science; 1985 May; 228(4702):996-9. PubMed ID: 2988126
[TBL] [Abstract][Full Text] [Related]
31. Immune response of humans to the circumsporozoite protein of Plasmodium falciparum: limited T cell response to the immunodominant central repeat region.
Campbell JR; Paleologo FP; Franke ED; Ratiwayanto S; Hadiputranto H; Kurniawan L; Wistar R; Hoffman SL; Annis BA; Wasserman G
Am J Trop Med Hyg; 1988 Sep; 39(3):232-5. PubMed ID: 2459979
[TBL] [Abstract][Full Text] [Related]
32. The immunologic significance of variation within malaria circumsporozoite protein sequences.
De La Cruz VF; Maloy WL; Miller LH; Good MF; McCutchan TF
J Immunol; 1989 May; 142(10):3568-75. PubMed ID: 2523929
[TBL] [Abstract][Full Text] [Related]
33. Antigenic diversity in Plasmodium falciparum.
McCutchan TF; de la Cruz VF; Good MF; Wellems TE
Prog Allergy; 1988; 41():173-92. PubMed ID: 2457215
[No Abstract] [Full Text] [Related]
34. Naturally acquired antibodies to sporozoites do not prevent malaria: vaccine development implications.
Hoffman SL; Oster CN; Plowe CV; Woollett GR; Beier JC; Chulay JD; Wirtz RA; Hollingdale MR; Mugambi M
Science; 1987 Aug; 237(4815):639-42. PubMed ID: 3299709
[TBL] [Abstract][Full Text] [Related]
35. Designing malaria vaccines to circumvent antigen variability.
Ouattara A; Barry AE; Dutta S; Remarque EJ; Beeson JG; Plowe CV
Vaccine; 2015 Dec; 33(52):7506-12. PubMed ID: 26475447
[TBL] [Abstract][Full Text] [Related]
36. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.
Wizel B; Houghten RA; Parker KC; Coligan JE; Church P; Gordon DM; Ballou WR; Hoffman SL
J Exp Med; 1995 Nov; 182(5):1435-45. PubMed ID: 7595214
[TBL] [Abstract][Full Text] [Related]
37. Malaria vaccines: immunogen selection and epitope mapping.
Perlmann P; Berzins K; Perlmann H; Troye-Blomberg M; Wahlgren M; Wåhlin B
Vaccine; 1988 Apr; 6(2):183-7. PubMed ID: 2455387
[TBL] [Abstract][Full Text] [Related]
38. Antigenic diversity and variation in blood stages of Plasmodium falciparum.
Kemp DJ
Immunol Cell Biol; 1992 Jun; 70 ( Pt 3)():201-7. PubMed ID: 1360446
[No Abstract] [Full Text] [Related]
39. Limited immunological recognition of critical malaria vaccine candidate antigens.
Good MF; Miller LH; Kumar S; Quakyi IA; Keister D; Adams JH; Moss B; Berzofsky JA; Carter R
Science; 1988 Oct; 242(4878):574-7. PubMed ID: 2902690
[TBL] [Abstract][Full Text] [Related]
40. Further studies on the antigenic diversity of the circumsporozoite proteins of the Plasmodium cynomolgi complex.
Cochrane AH; Gwadz RW; Barnwell JW; Kamboj KK; Nussenzweig RS
Am J Trop Med Hyg; 1986 May; 35(3):479-87. PubMed ID: 2422969
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
